Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Iowa hospital sued after allegedly extracting patient’s organs without family consent
In a lawsuit, the daughters of a deceased patient accuse Alegent Health-Community Memorial Hospital of Missouri Valley of medical malpractice and negligence, alleging donations were harvested without proper consultation. It’s alleged that their father was not registered as an organ donor.
Upfront costs of robotic heart surgery are high—but it may be a smart investment
Makoto Hashimoto, MD, PhD, said robotic procedures are associated with a faster recovery time and many other potential benefits.
Physician and his practice to pay $6.7M for allegedly performing unnecessary vascular procedures
The physician was accused of pressuring Medicare patients into undergoing treatment they did not need. One patient allegedly received 42 different stents over an eight-year period.
PHOTO GALLERY: Cardiac surgery technologies at the AATS 106th Annual Meeting
A wide variety of technologies, including robotic systems, heart valves, stent grafts, retractors and annuloplasty rings, were on display in Chicago.
Heart experts concerned after Trump administration authorizes fruit-flavored e-cigarettes
This is the first time the FDA has authorized market access for non-tobacco, non-menthol electronic nicotine delivery systems.

Medical malpractice gavel diagnostic error mistake stethoscope

Iowa hospital sued after allegedly extracting patient’s organs without family consent

In a lawsuit, the daughters of a deceased patient accuse Alegent Health-Community Memorial Hospital of Missouri Valley of medical malpractice and negligence, alleging donations were harvested without proper consultation. It’s alleged that their father was not registered as an organ donor.

Video of Makoto Hashimoto, MD, PhD, professor and director of robotic cardiac surgery at Florida International University, Baptist Health, who presented a study on robotic surgery outcomes and costs at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. While the costs of these minimally invasive robotic procedures is higher that traditional surgical procedures, he said costs overall can be reduced in terms of faster patient recovery, shorter length of stays.

Upfront costs of robotic heart surgery are high—but it may be a smart investment

Makoto Hashimoto, MD, PhD, said robotic procedures are associated with a faster recovery time and many other potential benefits.

Physician and his practice to pay $6.7M for allegedly performing unnecessary vascular procedures

The physician was accused of pressuring Medicare patients into undergoing treatment they did not need. One patient allegedly received 42 different stents over an eight-year period.

PHOTO GALLERY: Cardiac surgery technologies at the AATS 106th Annual Meeting

A wide variety of technologies, including robotic systems, heart valves, stent grafts, retractors and annuloplasty rings, were on display in Chicago.

Heart experts concerned after Trump administration authorizes fruit-flavored e-cigarettes

This is the first time the FDA has authorized market access for non-tobacco, non-menthol electronic nicotine delivery systems.

FDA adds surgical sponges, strips to list of shortages after Medline recall

Regulators said the shortages of neurosurgery devices are likely to extend until the end of the year. Medline recalled its neurosurgical patties due to a potential toxicity issue. The FDA said it's looking for alternatives.

Cannabis use increases risk of death, heart attack for ED patients

When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.

Kevin Accola, MD, a cardiac surgeon at Advent Health in Orlando, Florida, explains the 10-year results from the COMMENCE aortic trial that shows long-term durability and sustained performance of its Resilia surgical aortic valve. The data were presented at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. #AATS #AATS26 #AATS2026

Resilia tissue developed by Edwards Lifesciences associated with long-term durability

Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.